Skip to content

COMPARISON OF INTRAVENOUS PALONOSETRON, DEXAMETHASONE AND THEIR COMBINATION AS ANTIEMETIC THERAPY IN LAPAROSCOPIC SURGERIES

TO COMPARE THE EFFICACY OF INTRAVENOUS PALONOSETRON, DEXAMETHASONE AND A COMBINATION OF PALONOSETRON AND DEXAMETHASONE AS PROPHYLACTIC ANTIEMETIC THERAPY IN ADULT PATIENTS UNDERGOING LAPAROSCOPIC SURGERIES

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/07/007108
Enrollment
90
Registered
2016-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Adult ASA Grade I or II patients of either sex, aged 18 to 60 years, who underwent elective laparoscopic surgeries under general anaesthesia.

Interventions

Intervention1: Intravenous injection: Group P : Received Palonosetron 0.075 mg i.v Group D : Received Dexamethasone 8 mg i.v, diluted in normal saline Group P + D : Received Palonosetron 0.075 mg and

Sponsors

Dr Neha Sadhoo
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult ASA Grade I or II patients, who underwent elective laparoscopic surgeries under general anaesthesia.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating females 2. Patients older than 60 years or younger than 18 years of age 3. Patients with a history of central nervous system or neuromuscular disease 4. Patients with ASA physical status grade > II 5. Morbidly obese patients 6. Patients with hepatic, renal or cardio-respiratory disease 7. Patients with gastro-esophageal reflux 8. Patients with history of drug or alcohol abuse 9. Patients with known hypersensitivity to either Palonosetron or Dexamethasone 10. Patients with previous history of PONV or motion sickness 11. Patients receiving chemotherapy or radiotherapy

Design outcomes

Primary

MeasureTime frame
1. Incidence of PONV- using a 3- point scale ( 0-none, 1-nausea, 2- vomiting ). 2. Number of patients needing rescue antiemetic treatment. 3. Pain intensity scores- obtained with VAS test.Timepoint: 0, l, 2, 4, 8 and 24 hours

Secondary

MeasureTime frame
1. Heart rate 2. Blood pressure 3. Respiratory rate 4. Incidence of nausea and vomiting 5. Visual analogue scale scoreTimepoint: 0, l, 2, 4, 8 and 24 hours

Countries

India

Contacts

Public ContactDr Pavan Gurha

Guru Gobind Singh Indraprastha University

nehasadhoo@gmail.com9560509710

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026